CNR Institutional Research Information System

CATUOGNO, SILVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 904
NA - Nord America 739
EU - Europa 376
SA - Sud America 238
Continente sconosciuto - Info sul continente non disponibili 159
AF - Africa 25
OC - Oceania 3
Totale 2.444
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 676
SG - Singapore 399
BR - Brasile 183
IT - Italia 181
CN - Cina 172
VN - Vietnam 108
HK - Hong Kong 102
FR - Francia 52
NL - Olanda 50
CA - Canada 31
KR - Corea 29
AR - Argentina 23
JP - Giappone 22
DE - Germania 21
BD - Bangladesh 18
MX - Messico 16
FI - Finlandia 13
AT - Austria 12
EC - Ecuador 11
GB - Regno Unito 11
IN - India 11
CO - Colombia 8
ZA - Sudafrica 7
IL - Israele 6
IQ - Iraq 6
AL - Albania 5
IE - Irlanda 5
VE - Venezuela 5
EG - Egitto 4
ID - Indonesia 4
JM - Giamaica 4
MA - Marocco 4
NI - Nicaragua 4
PH - Filippine 4
PY - Paraguay 4
ES - Italia 3
PK - Pakistan 3
UA - Ucraina 3
AE - Emirati Arabi Uniti 2
BB - Barbados 2
BO - Bolivia 2
CZ - Repubblica Ceca 2
HN - Honduras 2
IR - Iran 2
KE - Kenya 2
MY - Malesia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
RS - Serbia 2
RU - Federazione Russa 2
SI - Slovenia 2
TR - Turchia 2
TW - Taiwan 2
UZ - Uzbekistan 2
AU - Australia 1
BE - Belgio 1
CD - Congo 1
CG - Congo 1
CL - Cile 1
CR - Costa Rica 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GH - Ghana 1
GR - Grecia 1
HU - Ungheria 1
IS - Islanda 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LT - Lituania 1
LY - Libia 1
ME - Montenegro 1
NO - Norvegia 1
PE - Perù 1
PL - Polonia 1
PR - Porto Rico 1
RO - Romania 1
SA - Arabia Saudita 1
SE - Svezia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
VC - Saint Vincent e Grenadine 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
ZM - Zambia 1
Totale 2.286
Salva come PNG Salva come JPEG
Città #
Singapore 240
Santa Clara 146
Hong Kong 102
San Jose 79
Ashburn 52
Beijing 45
Lauterbourg 44
Hefei 42
Ho Chi Minh City 41
Milan 39
Los Angeles 34
Marigliano 30
Seoul 28
Hanoi 24
São Paulo 21
Naples 20
Tokyo 19
Montreal 13
Dallas 12
New York 12
Frankfurt am Main 10
Helsinki 10
Vienna 8
Atlanta 7
Da Nang 7
Council Bluffs 6
Houston 6
Bogotá 5
Buffalo 5
Figino 5
Johannesburg 5
Philadelphia 5
Phoenix 5
Baltimore 4
Biên Hòa 4
Casandrino 4
Dhaka 4
Dublin 4
Düsseldorf 4
Genoa 4
Guayaquil 4
Kingston 4
Managua 4
Orem 4
Palermo 4
Princeton 4
Quito 4
Rio de Janeiro 4
The Bronx 4
Toledo 4
Toronto 4
Turin 4
Ascoli Piceno 3
Avellino 3
Belo Horizonte 3
Bengaluru 3
Betim 3
Brasília 3
Brooklyn 3
Cairo 3
Cincinnati 3
Guarulhos 3
Harrisburg 3
Jacksonville 3
London 3
Manaus 3
Medford 3
Miami 3
Milwaukee 3
Minamishinagawa 3
Plano 3
San Bernardino 3
São Gonçalo 3
São José dos Pinhais 3
Thái Bình 3
Alegrete 2
Almirante Tamandaré 2
Amsterdam 2
Auckland 2
Baghdad 2
Berlin 2
Bowie 2
Boydton 2
Bridgetown 2
Burnsville 2
Caivano 2
Campinas 2
Campos dos Goytacazes 2
Cape Town 2
Casablanca 2
Chicago 2
Ciudad del Este 2
Colombo 2
Columbiana 2
Corpus Christi 2
Cà Mau 2
Denver 2
Falkenstein 2
Feira de Santana 2
Fostoria 2
Totale 1.322
Salva come PNG Salva come JPEG
Nome #
Identification of a novel RNA aptamer that selectively targets breast cancer exosomes 103
Targeted systematic evolution of an RNA platform neutralizing DNMT1 function and controlling DNA methylation 95
New aptamer-based approaches for the targeting of cancer associated fibroblast in NSCLC 91
Directing in Vitro Selection towards G-quadruplex-forming Aptamers to Inhibit HMGB1 Pathological Activity 84
Selection of a nuclease‐resistant rna aptamer targeting cd19 79
STAT3 silencing by an aptamer-based strategy hampers the crosstalk between NSCLC cells and cancer-associated fibroblasts 76
Multifunctional Aptamer-miRNA Conjugates for Targeted Cancer Therapy 74
Emerging therapeutic RNAs for the targeting of cancer associated fibroblasts 68
Inhibition of Receptor Signaling and of Glioblastoma-derived Tumor Growth by a Novel PDGFR beta Aptamer 67
Stick-based methods for aptamer-mediated siRNA targeted delivery 66
Aptamer-based RNA-bio-drugs for the combined therapy of GBM 64
Axl-148b chimeric aptamers inhibit breast cancer and melanoma progression 64
The Small RNA Landscape in NSCLC: Current Therapeutic Applications and Progresses 63
Selection of RNA aptamers targeting hypoxia in cancer 61
An Anti-BCMA RNA Aptamer for miRNA Intracellular Delivery 61
Advances in mRNA non-viral delivery approaches 60
Axl-Targeted Delivery of the Oncosuppressor miR-137 in Non-small-Cell Lung Cancer 57
Advances in Oligonucleotide Aptamers for NSCLC Targeting 56
Identification of an interfering ligand aptamer for EphB2/3 receptors 55
STAT3 targeting by an aptamer-based conjugate for glioblastoma multiforme therapy 55
Targeting breast cancer exosomes with nucleic aptamers: Innovative tools for early diagnosis and therapy 54
Combined Targeting of Glioblastoma Stem-Like Cells by Neutralizing RNA-Bio-Drugs for STAT3 52
Nucleic acid aptamers targeting epigenetic regulators: An innovative therapeutic option 51
Aptamer chimeras for therapeutic delivery: The challenging perspectives 51
STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma 49
Nucleic acids delivering nucleic acids 47
An anti-PDGFR aptamer for selective delivery of small therapeutic peptide to cardiac cells 46
Selective delivery of therapeutic single strand antimiRs by aptamer-based conjugates 44
Targeting Insulin Receptor with a Novel Internalizing Aptamer. 39
Therapeutic Targeting of AXL Receptor Tyrosine Kinase Inhibits Tumor Growth and Intraperitoneal Metastasis in Ovarian Cancer Models 37
A combined microRNA-based targeted therapeutic approach to eradicate glioblastoma stem-like cells 36
miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis 35
Electrochemical detection of miRNA-222 by use of a magnetic bead-based bioassay 35
Recent advance in biosensors for microRNAs detection in cancer 35
Aptamer-miRNA conjugates for cancer cell-targeted delivery 35
Inhibition of Receptor Signaling and of Glioblastoma-derived Tumor Growth by a Novel PDGFR? Aptamer. 34
Coupling aptamers to short interfering RNAs as therapeutics 33
SERS-active metal-dielectric nanostructures integrated in microfluidic devices for label-free quantitative detection of miRNA 33
cleic acids in human glioma treatment: innovative approaches and recent results 32
Aptamer-mediated targeted delivery of therapeutics: An update 32
Directing in Vitro Selection towards G‐quadruplex‐forming Aptamers to Inhibit HMGB1 Pathological Activity 31
A Trojan horse for human immunodeficiency virus 31
New insight into clinical development of nucleic acid aptamers. 31
Developing aptamers by cell-based SELEX 29
Aptamer cell-based selection: Overview and advances 28
Aptamer-mediated selective delivery of short RNA therapeutics in cancer cells 27
Aptamer-based applications in delivering cancer gene therapies and beyond: state of the art and the missing links to clinical translation 25
The chimeric aptamer axl-miR-214sponge inhibits breast cancer and melanoma dissemination 24
Unraveling the NMR structures of G-quadruplex-forming aptamers acting as inhibitors of High Mobility Group Box 1 (HMGB1) pathological activity 9
Totale 2.444
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.263
article - articoli 7.899
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 364
Totale 16.526
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202440 0 0 0 0 0 0 0 0 1 0 27 12
2024/2025849 8 1 57 28 125 59 87 84 44 61 157 138
2025/20261.223 43 102 142 196 224 75 164 49 58 87 51 32
2026/2027332 108 74 150 0 0 0 0 0 0 0 0 0
Totale 2.444